Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.
- DOI
- 10.1016/j.jocn.2026.112195
- Published
- 2026 Oct
- Container
- Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jocn.2026.112195,
title = {Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.},
author = {Hernández-Bernal F and Subirós-Martínez N and Gutiérrez-Ronquillo JH and Colina-Ávila E and Guevara-Rodríguez M and Estenoz-García D and Catasús-Álvarez K and Martín-Bauta Y and Pérez-Saad H and Manso-López AM and Batista-Izquierdo A and González-Dalmau E and Amador-Nuñez T and Muzio-González VL and Guillén-Nieto GE and Garcia-Del-Barco-Herrera D and COURAGE COmbined therapeUtic appRoAch durinG acute strokE Research Group},
year = {2026},
journal = {Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia},
doi = {10.1016/j.jocn.2026.112195},
url = {https://doi.org/10.1016/j.jocn.2026.112195}
}RIS
TY - JOUR TI - Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke. AU - Hernández-Bernal F AU - Subirós-Martínez N AU - Gutiérrez-Ronquillo JH AU - Colina-Ávila E AU - Guevara-Rodríguez M AU - Estenoz-García D AU - Catasús-Álvarez K AU - Martín-Bauta Y AU - Pérez-Saad H AU - Manso-López AM AU - Batista-Izquierdo A AU - González-Dalmau E AU - Amador-Nuñez T AU - Muzio-González VL AU - Guillén-Nieto GE AU - Garcia-Del-Barco-Herrera D AU - COURAGE COmbined therapeUtic appRoAch durinG acute strokE Research Group PY - 2026 JO - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia DO - 10.1016/j.jocn.2026.112195 UR - https://doi.org/10.1016/j.jocn.2026.112195 ER -
APA
F, H., N, S., JH, G., E, C., M, G., D, E., K, C., Y, M., H, P., AM, M., A, B., E, G., T, A., VL, M., GE, G., D, G., & Group, C. C. T. A. D. A. S. R. (2026). Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. https://doi.org/10.1016/j.jocn.2026.112195
Source records
- pubmed · retrieved 2026-09-26T14:56:55.495Z